Author
Listed:
- Thomas R. Insel
(Thomas R. Insel is at the National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.)
- Barbara J. Sahakian
(University of Cambridge, Cambridge, UK. bjs1001@cam.ac.uk)
- Valerie Voon
(University of Cambridge, Cambridge, UK.)
- Jeffrey Nye
(Jeffrey Nye is at Janssen Pharmaceutical of Johnson and Johnson, Titusville, New Jersey, USA.)
- Verity J. Brown
(Verity J. Brown is in the School of Psychology, St Andrews University, St Andrews, UK.)
- Bruce M. Altevogt
(Bruce M. Altevogt is at the Institute of Medicine, Forum on Neuroscience and Nervous System Disorders, Washington DC, USA.)
- Ed T. Bullmore
(Ed T. Bullmore is at GlaxoSmithKline, Clinical Unit, Addenbrookes Hospital, Cambridge, UK.)
- Guy M. Goodwin
(University of Oxford, Oxford, UK.)
- Robert J. Howard
(Robert J. Howard is at the Royal College of Psychiatrists and Institute of Psychiatry, King’s College London, London, UK.)
- David J. Kupfer
(David J. Kupfer is in the University of Pittsburgh School of Medicine, Pittsburg, Pennsylvania, USA.)
- Gavin Malloch
(Gavin Malloch is at the Medical Research Council, London, UK.)
- Hugh M. Marston
(Hugh M. Marston is at TPP Global Development, Edinburgh, UK.)
- David J. Nutt
(David J. Nutt is at the Centre for Pharmacology and Therapeutics, Imperial College London, London, UK.)
- Trevor W. Robbins
(University of Cambridge, Cambridge, UK.)
- Stephen Stahl
(Stephen Stahl is in the Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK, University of California, San Diego, San Diego, California, USA.)
- Mark D. Tricklebank
(Mark D. Tricklebank is at Eli Lilly and Co Ltd, Windlesham, UK.)
- John H. Williams
(John H. Williams is at the Wellcome Trust, London, UK.)
Abstract
The Royal Society International Seminar Consortium describes what the next decade of mental-health drug development should look like.
Suggested Citation
Thomas R. Insel & Barbara J. Sahakian & Valerie Voon & Jeffrey Nye & Verity J. Brown & Bruce M. Altevogt & Ed T. Bullmore & Guy M. Goodwin & Robert J. Howard & David J. Kupfer & Gavin Malloch & Hugh M, 2012.
"A plan for mental illness,"
Nature, Nature, vol. 483(7389), pages 269-269, March.
Handle:
RePEc:nat:nature:v:483:y:2012:i:7389:d:10.1038_483269a
DOI: 10.1038/483269a
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:483:y:2012:i:7389:d:10.1038_483269a. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.